High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation

Human Gene Therapy

Volumn 7, Issue 16, 1996, Pages 1971-1980

  Lahijani, Roya ^a   Hulley, Giles ^a   Soriano, Grace ^a   Horn, Nancy A ^a   Marquet, Magda ^a  

^a VICAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; RNA;

ARTICLE; CONTROLLED STUDY; DNA REPLICATION; FERMENTATION; GENE THERAPY; NONHUMAN; PLASMID; POINT MUTATION; TEMPERATURE SENSITIVE MUTANT;

EID: 0029796205     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.16-1971     Document Type: Article

References (41)

1. BACHVAROV, D., JAY, E., and IVANOV, I. (1990). Construction of a ColE1 plasmid bearing inducible high-copy-number phenotype. Folia Microbiol. 35, 177-182.
2. BACKMAN, K., BETLACH, M., BOYER, H.W., and YANOFSKY, S. (1979). Genetic and physical studies on the replication of ColE1-type plasmids. Cold Spring Harbor Symp. Quant. Biol. 43, 69-76.
3. BALBAS, P., SOBERON, X., MERINO, E., ZURITA, M., LOMELI, H., VALLE, F., FLORES, N., and BOLIVAR, F. (1986). Plasmid vector pBR322 and its special-purpose derivatives - a review. Gene 50, 3-40.
4. BOLIVAR, F., RODRIGUEZ, R.L., GREEN, P.J., BETLACH, M.C., HEYNEKER, H.L., BOYER, H.W., CROSA, J.H., and FALKOW, S. (1977). Construction and characterization of new cloning vehicles. II. A multi-purpose cloning system. Gene 2, 95-113.
5. BOROS, I., POSFAI, G., and VENETIANER, P. (1984). High-copy-number derivatives of the plasmid cloning vector pBR322. Gene 30, 257-260.
6. CESARENI, G., HELMER-CITTERICH, M., and CASTAGNOLI, L. (1991). Control of ColE1 plasmid replication by antisense RNA. Trends Genet. 7, 230-235.
7. CHANG, A.E., YOSHIZAWA, H., SAKAI, K., CAMERON, M.J., SONDAK, V.K., and SHU, S. (1993). Clinical observation on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro. Cancer Res. 53, 1043-1050.
8. CLEWELL, D.B. (1972). Nature of ColE1 plasmid replication in Escherichia coli in the presence of chloramphenicol. J. Bacteriol. 110, 667-676.
9. DAVISON, J. (1984). Mechanism of control of DNA replication and incompatibility in ColE1-type plasmids - a review. Gene 28, 1-15.
10. DAVISON, J., HEUSTERSPREUTE, M., MERCHEZ, M., and BRUNEL, F. (1984). Vectors with restriction-site banks I. pJRD158, a 3903-bp plasmid containing 28 unique cloning sites. Gene 28, 311-318.
11. FELGNER, P.L. (1990). Particulate systems and polymers for in vitro and in vivo delivery of polynucleotides. Adv. Drug Delivery Rev. 5, 167-187.
12. FELGNER, J., KUMAR, R., SRIDHAR, C., WHEELER, C., TSAI, Y., BORDER, R., RAMSEY, P., MARTIN, M., and FELGNER, P. (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269, 2550-2561.
13. HESCHKO, J., and RITCH, T. (1986). Production of human alpha consensus interferon in recombinant Escherichia coli. Chem. Eng. Commun. 45, 229-240.
14. FITZWATER, T., ZHANG, X., ELBLE, R., and POLISKY, B. (1988). Conditional high copy number ColE1 mutants: resistance to RNA 1 inhibition in vivo and in vitro. EMBO J. 7, 3289-3297.
15. HERMAN, A., WEGRZYN, A., and WEGRZYN, G. (1994). Combined effect of stringent or relaxed response, temperature and rom function on the replication of pUC plasmids in Escherichia coli. Acta Biochim. Polonica 41, 122-124.
16. HORN, N., MEEK, J., BUDAHAZI, G., and MARQUET, M. (1995). Cancer gene therapy using plasmid DNA: Purification of DNA for human clinical trials. Hum. Gene Ther. 6, 565-573.
17. JUNG, G., DENEFLE, P., BECQUART, J., and MAYAUX, J.F. (1988). High-Cell Density fermentation studies of recombinant Escherichia coli strains expressing human interleukin-1β. Ann. Inst. Pasteur/Microbiol. 139, 129-146.
18. LEDLEY, F. (1995). Nonviral gene therapy: The promise of genes as pharmaceutical products. Hum. Gene Ther. 6, 1129-1144.
19. LEW, D., PARKER, S., LATIMER, T., ABAI, A., KUWAHARA-RUNDELL, A., DOH, G., YANG, Z., LAFACE, D., GROMKOWSKI, S., NABEL, G., MANTHORPE, M., and NORMAN, J. (1995). Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice. Human gene therapy, 6, 553-564.
20. LIN-CHAO, S., CHEN, W., and WONG, T. (1992). High copy number of the pUC plasmid results from a Rom/Rop-suppressible point mutation in RNA II. Mol. Microbiol. 6, 3385-3393.
21. LULI, G., and STROHL, W. (1990). Comparison of growth, acetate production, and acetate inhibition of E. coli strains in batch and fed-batch fermentations. Appl. Environ. Microbiol. 56, 1004-1011.
22. MANIATIS, T., FRITSCH, E.F., and SAMBROOK, J. (1982). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 368-369.
23. MASHKO, S., MOCHULSKY, A., KOTENKO, S., LEBEDEVA, M., LAPIDUS, A., MOCHULSKAYA, N., IZOTOVA, L., VEIKO, V., VINETSKY, Y., KETLINSKY, S., and DBAHOV, V. (1991). Use of dual-origin temperature-controlled amplifiable replicon for optimization of human interleukin-1β synthesis in Escherichia coli. Gene 97, 259-266.
24. MIKI, T., YASUKOCHI, T., NAGATANI, H., FURUNO, M., ORITA, T., YAMADA, H., IMOTO, T., and HORIUCHI, T. (1987). Construction of a plasmid vector for the regulatable high level expression of eukaryotic genes in Escherichia coli: An application to overproduction of chicken lysozyme. Prot. Eng. 1, 327-332.
25. MINTON, N.P. (1984). Improved plasmid vectors for the isolation of translational lac gene fusions. Gene 31, 269-273.
26. MINTON, N.P., CHAMBERS, S.P., PRIOR, S.E., COLE, S.T., and GARNIER, T. (1988). Copy number and mobilization properties of pUC plasmids. Bethesda Res. Lab. Focus 10, 56.
27. NABEL, G.J., CHANG, A., NABEL, E.G., PLAUTZ, G., FOX, B.A., HUANG, L., and SHU, S. (1992). Immunotherapy of malignancy by in vivo gene transfer into tumors. Hum. Gene Ther. 3, 399-410.
28. NABEL, G.J., NABEL, E.G., YANG, Z-Y., FOX, B.A., PLAUTZ, G.E., GAO, X., HUANG, L., SHU, S., GORDEN, D., and CHANG, A.E. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90, 11307-11311.
29. PAALME, T., TIISMA, K., KAHRU, A., VANATALU, K., and VILU, R. (1990) Glucose-limited fed-batch cultivation of Escherichia coli with computer-controlled fixed growth rate. Biotechnol. Bioeng. 35, 312-319.
30. PANAYOTATOS, N. (1984). DNA replication regulated by the priming promoter. Nucleic Acids Res. 12, 2641-2648.
31. PARKER, S., KHATIBI, S., MARGALITH, M., ANDERSON, D., YANKAUCHAS, M., GROMKOWSKI, S., LATIMER, T., LEW, D., MARQUET, M., MANTHORPE, M., HOBART, P., HERSH, E., STOPECK, A., and NORMAN, J. (1996). Plasmid DNA gene therapy: Studies with the human IL-2 gene in tumor cells in vitro and in the murine melanoma model in vivo. Cancer Gene Ther. 3, 175-185.
32. RIETHDORF, S., ULRICH, A., and HECKER, M. (1991). Replication of ColE1-related plasmids at increased growth temperature depending on rom function. Zeitschrift Fur Naturforschung, section C. J. Biosci. 46, 1063-1066.
33. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) p. A-2.
34. TWIGG, A.J., and SHERRATT, D. (1980). Trans-complementable copy-number mutants of plasmid ColE1. Nature 283, 216-218.
35. TOMIZAWA, J. (1990). Control of ColE1 plasmid replication interaction of Rom protein with an unstable complex formed by RNA I and RNA II. J. Mol. Biol. 212, 695-708.
36. VIEIRA, J., and MESSING, J. (1982). The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19, 259-268.
37. WRIGHT, E., HUMPHREYS, G., and YARRANTON, G. (1986). Dual-origin plasmids containing an amplifiable ColE1 ori; temperature-controlled expression of cloned genes. Gene 49, 311-321.
38. YANISCH-PERRON, C., VIEIRA, J., and MESSING, J. (1985). Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33, 103-119.
39. L. Gene 28, 293-300.
40. YEE, L., and BLANCH, H.W. (1992). Recombinant protein expression in high cell density fed-batch cultures of Escherichia coli. Biotechnology 10, 1550-1556.
41. ZABRISKIE, D.W., WAREHEIM, D.A., and POLANSKY, M.J. (1987). Effects of fermentation feeding strategies prior to induction of expression of a recombinant malaria antigen in Escherichia coli. J. Ind. Microbiol. 2, 87-95.